Alpha 2.0
Login Register
» Articles » PMID: 3986080

Effects of Ranitidine on the Disposition of Metoprolol

Overview
Journal Br J Clin Pharmacol
Specialty Pharmacology
Date 1985 Feb 1
PMID 3986080
Citations 15
Authors
J G Kelly
S A Salem
C D Kinney
R G Shanks
D G McDevitt
Affiliations
Soon will be listed here.
Abstract

The effects of ranitidine on the pharmacokinetics of metoprolol were examined in two studies. In the first study, pharmacokinetics of single doses of metoprolol were examined in six subjects before, during and after ranitidine administration for 1 week. Peak concentrations of metoprolol were increased on ranitidine but its half-life and clearance were unaltered. In the second study, 12 subjects received metoprolol twice daily for 1 week; once with ranitidine and once with placebo. Ranitidine had no effects on the chronic-dose pharmacokinetics or pharmacodynamics of metoprolol. The chronic dose study suggests no inhibition of the metabolism of metoprolol by ranitidine. The single dose study suggests, however, that some interaction of an as yet unknown nature, cannot be excluded.

Citing Articles

Clinical Pharmacokinetics of Metoprolol: A Systematic Review.

Zamir A, Hussain I, Ur Rehman A, Ashraf W, Imran I, Saeed H Clin Pharmacokinet. 2022; 61(8):1095-1114.

PMID: 35764772 DOI: 10.1007/s40262-022-01145-y.

Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions.

Rudesheim S, Wojtyniak J, Selzer D, Hanke N, Mahfoud F, Schwab M Pharmaceutics. 2020; 12(12).

PMID: 33322314 PMC: 7763912. DOI: 10.3390/pharmaceutics12121200.

Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Tfelt-Hansen P, Agesen F, Pavbro A, Tfelt-Hansen J CNS Drugs. 2017; 31(5):389-403.

PMID: 28405886 DOI: 10.1007/s40263-017-0430-3.

Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.

Isoherranen N, Lutz J, Chung S, Hachad H, Levy R, Ragueneau-Majlessi I Chem Res Toxicol. 2012; 25(11):2285-300.

PMID: 22823924 PMC: 3502654. DOI: 10.1021/tx300192g.

Drug interactions between prescribed and over-the-counter medication.

Honig P, Gillespie B Drug Saf. 1995; 13(5):296-303.

PMID: 8785017 DOI: 10.2165/00002018-199513050-00003.

References
1.
Regardh C, Borg K, Johansson R, Johnsson G, Palmer L . Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man. J Pharmacokinet Biopharm. 1974; 2(4):347-64. DOI: 10.1007/BF01061407. View
2.
Wilkinson G, SHAND D . Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975; 18(4):377-90. DOI: 10.1002/cpt1975184377. View
3.
Serlin M, Sibeon R, Mossman S, Breckenridge A, Williams J, Atwood J . Cimetidine: interaction with oral anticoagulants in man. Lancet. 1979; 2(8138):317-9. DOI: 10.1016/s0140-6736(79)90340-4. View
4.
Henry D, MacDonald I, Kitchingman G, Bell G, Langman M . Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br Med J. 1980; 281(6243):775-7. PMC: 1714006. DOI: 10.1136/bmj.281.6243.775. View
5.
Feely J, Wilkinson G, Wood A . Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med. 1981; 304(12):692-5. DOI: 10.1056/NEJM198103193041202. View